Detect key clinical trial events, identify trends, and spot outliers from data as soon as it becomes available and go from analysis to action in a fraction of the time.
AXL-1 is specifically trained and fine-tuned using proprietary event data, and clinical trials data interpretations. This specialized approach, coupled with data annotations by journalists, significantly enhances the model's accuracy.
AXL-1 can directly source data from the origin and provide citations for the clinical trials mentioned and other data retrieved, enhancing transparency, reliability and trust.